Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vesicare (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.

Trial Profile

Vesicare (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Urinary incontinence
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2014 Status changed from discontinued to completed to match the status with ClinicalTrials.gov record (NCT01215721).
    • 12 Jun 2014 Status changed from discontinued to completed to match the status with ClinicalTrials.gov record (NCT01215721).
    • 04 Sep 2013 The extension trial is now completed according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top